316. カルニチン回路異常症 Carnitine cycle disorder Clinical trials / Disease details

臨床試験数 : 4 / 薬物数 : 10 - (DrugBank : 4) / 標的遺伝子数 : 2 - 標的パスウェイ数 : 11

2 trials found

diseases per page:

Showing 1 to 2 of 2 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT00983788 (ClinicalTrials.gov)	October 2009	23/9/2009	Effect of Bezafibrate on Muscle Metabolism in Patients With Fatty Acid Oxidation Defects	Evaluation of the Effect of Bezafibrateon Muscle Metabolism During Exercise in Patients With CPTII a ...	Carnitine Palmitoyltransferase II Deficiency;Very Long Chain Acyl Coa Dehydrogenase Deficiency	Drug: Bezafibrate;Other: Placebo	Rigshospitalet, Denmark	Institut de Myologie, Pitié-Salpêtrière Hospital, France	Completed	18 Years	70 Years	Both	12	Phase 2	Denmark
2	NCT00336167 (ClinicalTrials.gov)	June 2006	9/6/2006	Bezafibrate Trial in CPT2 Deficiency	Clinical Trial on the Effect of Bezafibratein the Muscular Form of Carnitine Palmitoyltransferase 2 ...	Carnitine Palmitoyl Transferase 2 Deficiency	Drug: bezafibrate (drug)	Assistance Publique - Hôpitaux de Paris	Association Française contre les Myopathies (AFM), Paris;Institut National de la Santé Et de la Rech ...	Recruiting	18 Years	N/A	Both	12	Phase 3	France

First Previous1Next Last